Ma Y, Sturrock A, Weis J J
Department of Pathology, University of Utah School of Medicine, Salt Lake City 84132.
Infect Immun. 1991 Feb;59(2):671-8. doi: 10.1128/iai.59.2.671-678.1991.
The later stages of infection by the Lyme disease pathogen, Borrelia burgdorferi, are characterized by the persistence of the organism in individuals possessing a strong anti-Borrelia immune response. This suggests that the organism is sequestered in a tissue protected from the immune system of the host or there is a reservoir of the organism residing within the cells of the host. In this report, the ability of B. burgdorferi to gain entrance into human umbilical vein endothelial cells was explored as a model for invasion. Incubation of B. burgdorferi with human umbilical vein endothelial cells at ratios ranging from 200:1 to 5,000:1 resulted in the intracellular localization of 10 to 25% of B. burgdorferi in 24 h. The intracellular location of the spirochetes was demonstrated by the incorporation of radiolabeled B. burgdorferi into a trypsin-resistant compartment and was confirmed by double-immunofluorescence staining which differentiated intracellular from extracellular organisms. Actin-containing microfilaments were required for the intracellular localization, indicating that the host cell participates in the internalization process. Activation of endothelial cells by agents known to increase the expression of several adhesion molecules had no effect on the interaction of B. burgdorferi with the endothelial monolayer. This indicates that the endothelial receptor for B. burgdorferi is constitutively expressed and that internalization is not dependent upon adhesion molecules whose expression is induced by inflammatory mediators. The demonstration of B. burgdorferi within endothelial cells suggest that intracellular localization may be a potential mechanism by which the organism escapes from the immune response of the host and may contribute to persistence of the organism during the later stages of Lyme disease.
莱姆病病原体伯氏疏螺旋体感染的后期阶段,其特征是该病原体在具有强烈抗伯氏疏螺旋体免疫反应的个体中持续存在。这表明该病原体被隔离在一个免受宿主免疫系统影响的组织中,或者在宿主细胞内存在一个病原体储存库。在本报告中,研究了伯氏疏螺旋体进入人脐静脉内皮细胞的能力,以此作为侵袭模型。将伯氏疏螺旋体与人脐静脉内皮细胞以200:1至5000:1的比例孵育24小时后,10%至25%的伯氏疏螺旋体定位于细胞内。通过将放射性标记的伯氏疏螺旋体掺入对胰蛋白酶有抗性的区室,证明了螺旋体在细胞内的定位,并通过双免疫荧光染色得到证实,该染色可区分细胞内和细胞外的病原体。细胞内定位需要含肌动蛋白的微丝,这表明宿主细胞参与了内化过程。已知可增加几种黏附分子表达的试剂对内皮细胞的激活,对伯氏疏螺旋体与内皮单层的相互作用没有影响。这表明伯氏疏螺旋体的内皮受体是组成性表达的,内化并不依赖于由炎症介质诱导表达的黏附分子。伯氏疏螺旋体在内皮细胞内的证实表明,细胞内定位可能是该病原体逃避宿主免疫反应的一种潜在机制,并且可能有助于莱姆病后期病原体的持续存在。